Carbamazepine effect in trigeminal neuragia
Not Applicable
- Conditions
- trigeminal neuralgia.Syndrome of paroxysmal facial pain Tic douloureux
- Registration Number
- IRCT201202219103N1
- Lead Sponsor
- Yazd Shadid Sadoughi University of Medical Science, Dental School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients with trigeminal neuralgia
Exclusion criteria: Patients with trigeminal neuralgia and other systemic diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical functional score. Timepoint: 1 week, 3 weak, 2 mounth, 3 mounth, 4 mounth. Method of measurement: 1) same pain 2) tingling and shocking pain 3)tingling 4)complete resolve.;Pain intensity changes. Timepoint: 1 week, 3 weak, 2 mounth, 3 mounth, 4 mounth. Method of measurement: vas.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: 3 weeks. Method of measurement: Laboratory tests.